Evidence map›Paper›PMID 38200396›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2024

Combination of [

Jisu Kim, Seunghwan Lee, Dongwoo Kim, Hyun Jeong Kim, Kyeong Taek Oh, Sun Jung Kim, Young Deuk Choi, Frederik L Giesel, Klaus Kopka, Alexander Hoepping and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Distinct prognostic value of [Communications medicine · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Use ofWiener klinische Wochenschrift · 2025
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Jisu Kim *Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, South Korea.
Seunghwan Lee *Department of Urology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Dongwoo KimDepartment of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, South Korea.
Hyun Jeong KimDepartment of Nuclear medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea.
Kyeong Taek OhDepartment of Medical Engineering, Yonsei University College of Medicine, Seoul, South Korea.
Sun Jung KimDepartment of Nuclear Medicine, National Health Insurance Service Ilsan Hospital, Goyang, South Korea.
Young Deuk ChoiDepartment of Urology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Frederik L GieselDepartment of Nuclear Medicine, Medical Faculty, Heinrich-Heine-University, University Hospital Duesseldorf, Duesseldorf, Germany.
Klaus KopkaInstitute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany.
Alexander HoeppingABX Advanced Biochemical Compounds GmbH, Heinrich-Glaeser-Strasse 10-14, 01454, Radeberg, Germany.
Misu LeeDivision of Life Sciences, College of Life Science and Bioengineering, Incheon National University, Incheon, South Korea. misulee@inu.ac.kr.
Mijin YunDepartment of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, South Korea. YUNMIJIN@yuhs.ac.
Severance Hospital · KRYonsei University · KRABX-CRO Advanced Pharmaceutical Services (Germany) · DEHeinrich Heine University Düsseldorf · DEHelmholtz-Zentrum Dresden-Rossendorf · DEIncheon National University · KRNational Health Insurance Service · KR

Funding

National Research Foundation of Korea NRF-2016K1A3A1A48953207National Research Foundation of Korea NRF-2020R1A2B5B01098109National Research Foundation of Korea RS-2022-00144475
6 · The paper itself

Abstract

purpose[

methodThis prospective study included 42 index tumours (27 acinar and 15 ductal-dominant) in 42 patients who underwent [

resultsAll 42 index tumours were detected on [

conclusions[

Indexed as

Fluorodeoxyglucose F18Neoplasm StagingPositron Emission Tomography Computed TomographyProstatic NeoplasmsAgedHumansMaleMiddle AgedNiacinamideOligopeptidesPostoperative PeriodProspective StudiesRadiopharmaceuticalsFluorodeoxyglucose F18NiacinamideOligopeptidesPSMA-1007Radiopharmaceuticals[18F]FDG[18F]PSMA-1007 PET/CTBiochemical failureCancer metabolismCancer stagingProstate

Identifiers

PMID38200396
OpenAlexW4390719015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.